Zhejiang Orient Gene Biotech Co Ltd Cash Flow Quality Index
Zhejiang Orient Gene Biotech Co Ltd cash flow quality index. Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Quality Index of -5.35x as of June 2023. Operating cash flow of CN¥-455.48 Million is below net income of CN¥85.14 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zhejiang Orient Gene Biotech Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Cash flow quality index of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2022. Historical Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. See debt-free asset ratio of Zhejiang Orient Gene Biotech Co Ltd to measure how much of total assets are equity-financed.
Zhejiang Orient Gene Biotech Co Ltd Cash Flow Quality Index by Year (2016–2022)
Zhejiang Orient Gene Biotech Co Ltd cash flow quality index by year from 2016 to 2022. Year-by-year earnings quality comparison for Zhejiang Orient Gene Biotech Co Ltd. For the full cash flow conversion analysis, see Zhejiang Orient Gene Biotech Co Ltd cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.43x | CN¥3.00 Billion | CN¥2.10 Billion | ▲ +35.6% |
| 2021 | 1.05x | CN¥5.20 Billion | CN¥4.94 Billion | ▼ -1.1% |
| 2020 | 1.07x | CN¥1.79 Billion | CN¥1.68 Billion | ▲ +52.3% |
| 2019 | 0.70x | CN¥54.21 Million | CN¥77.51 Million | ▲ +0.9% |
| 2018 | 0.69x | CN¥44.33 Million | CN¥63.96 Million | ▼ -32.4% |
| 2017 | 1.03x | CN¥33.54 Million | CN¥32.71 Million | ▲ +209.4% |
| 2016 | 0.33x | CN¥11.81 Million | CN¥35.63 Million | — |